Rating History for Theravance Biopharma (TBPH) by H.C. Wainwright
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 7/7/2026 | Douglas Tsao | Downgrade | Neutral (Buy) |
N/A (N/A) |
17.00 (16.93) |
-0.41% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 7/7/2026 | Douglas Tsao | Downgrade | Neutral (Buy) |
N/A (N/A) |
17.00 (16.93) |
-0.41% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||